meglumine has been researched along with Drug Abuse, Intravenous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hajiabdolbaghi, M; Hajjaran, H; Hashemian, H; Jafari, S; Mohebali, M | 1 |
Bongrand, MC; Chochoi, N; Faraut, F; Gallais, H; Gensollen, S; Monges, P; Montana, M; Ravaux, I; Timon-David, P | 1 |
Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F | 1 |
Márquez, M; Rivero, A; Santos, J | 1 |
2 review(s) available for meglumine and Drug Abuse, Intravenous
Article | Year |
---|---|
[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].
Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome | 2004 |
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous | 2000 |
2 other study(ies) available for meglumine and Drug Abuse, Intravenous
Article | Year |
---|---|
Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Biopsy; CD4 Lymphocyte Count; Humans; Immunocompromised Host; Iran; Leishmania tropica; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Substance Abuse, Intravenous; Travel | 2010 |
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous | 1994 |